Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4, indicating a new build of the site. It is a technical update that does not modify study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-08-08T20:04:10.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a minor deployment/update. No content changes are indicated by the data provided.
    Difference
    0.0%
    Check dated 2026-07-25T12:50:02.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The site footer revision shows v3.6.3, replacing the previous v3.6.2. This indicates a new software release for the ClinicalTrials.gov interface, likely including fixes or enhancements.
    Difference
    0.0%
    Check dated 2026-07-04T03:51:03.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Expanded the study’s location network to 260 sites by adding several new centers (eg Hospital da Luz in Lisbon; Hubei Cancer Hospital in Wuhan; Tianjin Medical University General Hospital; The Second Peoples Hospital of Neijiang; Haikou Peoples Hospital; Saiseikai Matsusaka Municipal Hospital) across multiple countries. The deletions remove Matsusaka Municipal Hospital and Adana Baskent University, and the total location count changes from 254 to 260.
    Difference
    0.5%
    Check dated 2026-06-27T01:33:56.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate the study is no longer enrolling, and new navigation/help sections were added while a few header labels were adjusted; these changes mainly affect how users access information rather than altering the trial's design or outcomes.
    Difference
    0.1%
    Check dated 2026-06-12T16:35:30.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5. This appears to be a minor metadata/UI update with no changes to study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-06-05T11:35:40.000Z thumbnail image

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.